Form 4: BWX Technologies Director James M. Jaska Reports Acquisition of Dividend Equivalent Rights

Sentiment:

SEC Form 4 Filing


Director James M. Jaska reports acquiring dividend equivalent rights related to restricted stock units of BWX Technologies.

Summary

  • On September 5, 2024, James M. Jaska, a director of BWX Technologies, Inc. (BWXT), acquired 34.58 dividend equivalent rights (DER) related to previously granted restricted stock units (RSUs).
  • These DERs accrued on six restricted stock unit grants for which Jaska has elected to defer receipt of the underlying shares.
  • Each RSU and DER represents a contingent right to receive one share of BWXT common stock.
  • The DERs will be delivered to Jaska proportionately with the RSUs to which they relate.
  • Following the transaction, Jaska directly owns 926.23 derivative securities.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, and there is no inherent positive or negative sentiment associated with it. It simply reports a transaction.

Future Outlook

The dividend equivalent rights will be delivered to the reporting person proportionately with the RSUs to which they relate.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions, providing transparency into the holdings and transactions of company directors. It is a standard practice for publicly traded companies and their executives.

Comparison to Industry Standards

  • Form 4 filings are a standard regulatory requirement for publicly traded companies in the United States, ensuring transparency in insider trading activities.
  • Companies like Lockheed Martin, General Dynamics, and Northrop Grumman also have similar reporting requirements for their executives and directors.
  • The reporting of dividend equivalent rights is common when executives hold restricted stock units and elect to defer the receipt of shares.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders, as it involves the acquisition of dividend equivalent rights by a director, which is part of their compensation package.
  • The filing provides transparency to shareholders regarding insider transactions.

Key Dates

DateDescription
09/05/2024Date of transaction: Acquisition of dividend equivalent rights.
09/09/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.